Why You're Low on Acetylcholine — and Why Taking Choline Alone Won't Fix It

By Dr. Ben Lynch, ND | Bestselling Author of Dirty Genes | Founder, Seeking Health

---

KEY TAKEAWAYS

• Acetylcholine is not made from one ingredient. It requires three inputs working together: choline, acetyl-CoA, and an enzyme called ChAT. If any one of them is missing or impaired, production fails.
• Most people are significantly low on choline. Fewer than 7% of U.S. adults meet the adequate intake. Without eggs in the diet, that number drops to 2.4%.
• Vitamin B5 is the overlooked input. Without B5, acetyl-CoA cannot form. No acetyl-CoA means no acetylcholine, regardless of how much choline you take.^†
• Making acetylcholine is only half the battle. An enzyme called AChE destroys it. When this enzyme is upregulated by inflammation or high homocysteine, acetylcholine gets cleared before it can act.
• Two genetic factors dramatically increase your vulnerability: APOE4 impairs all three production steps simultaneously. MTHFR variants raise homocysteine, which both impairs production and accelerates destruction.
• Both can be tested. Homocysteine is a standard blood draw. APOE4 and MTHFR status come from a simple genetic panel. Your doctor almost certainly has not ordered them.
• Part 3 covers the protocol. The specific nutrients, the correct sequencing, and why the order matters as much as the ingredients.

You Tried Something. It Did Not Work.

Maybe you read about choline and bought a bottle. You took it for a few weeks and did not notice much difference. Or you tried B vitamins because someone said they helped with brain fog. Or you just kept using the nicotine pouches because at least those did something.

That experience is not a sign that nothing will help. It is a sign that you fixed one part of a three-part problem.

Acetylcholine production is not a single-ingredient process. Your brain needs three things to make it. Most people are missing more than one. Fix only one and nothing changes. That is exactly what a lot of supplement advice gets wrong.

Part 1 of this series established that nicotine is borrowing your acetylcholine receptors because the neurotransmitter that belongs there is running low. This article explains why it is running low, where the production chain breaks, and what makes some people significantly more vulnerable than others.

By the end of this article you will understand your own situation well enough to recognize which inputs are most likely failing for you. Part 3 translates that into a specific protocol.

Your Brain Needs Three Things to Make Acetylcholine

The production process looks like this:

Choline is an essential nutrient and the primary raw material for acetylcholine. Your brain cannot synthesize it in adequate amounts on its own. It comes from food. You either eat enough of it or you run low.^†

Acetyl-CoA is the energy unit your mitochondria produce. It requires vitamin B5 to form. Without it, choline has nothing to combine with.^†

ChAT — choline acetyltransferase — is the enzyme that assembles the two inputs into acetylcholine. It is the rate-limiting step. If it is slow or impaired, production slows no matter how much choline or B5 you have.

Then AChE, acetylcholinesterase, clears acetylcholine from the synapse. This is normal and necessary. The problem starts when AChE activity is higher than it should be and acetylcholine gets destroyed before it can do its job.

Most people who struggle with brain fog, focus, memory, or cognitive fatigue have a problem at more than one of these steps. That is why single-ingredient fixes usually disappoint.

Step One: The Choline Gap Is Bigger Than You Think

Fewer than 7% of U.S. adults meet the adequate intake for choline.¹ That number comes from NHANES data covering tens of thousands of people. It is not a fringe finding. The majority of the population is chronically low on the primary raw material for acetylcholine.

Eggs are the main driver. Adults who eat eggs regularly reach adequate choline intake at a rate of 57%. Adults who do not eat eggs: 2.4%.¹

Choline is found in liver, egg yolks, fish, and meat. Plant foods contain very little. A fully plant-based diet with no eggs and no supplementation almost guarantees a significant choline deficit. This is not a moral judgment about diet. It is a biochemical fact about where choline exists in the food supply.

Women after menopause face the highest risk

Estrogen induces an enzyme called PEMT that synthesizes choline inside the body.² Before menopause, this provides a meaningful buffer against dietary shortfalls. After menopause, estrogen drops, PEMT activity drops, and endogenous choline production falls with it.

In a controlled trial, 73% of postmenopausal women placed on a low-choline diet developed signs of organ dysfunction.³ That is not a rare outlier. It is what happens when the estrogen-driven backup system is gone and dietary intake is insufficient.

If you are postmenopausal and struggling with cognitive symptoms, choline status is one of the first things to examine. Your doctor almost certainly has not brought it up.

Step Two: The Input Nobody Mentions

Choline gets most of the attention. Acetyl-CoA gets almost none.

Acetyl-CoA is produced in your mitochondria. It requires vitamin B5, also called pantothenic acid, as a cofactor. Without adequate B5, your mitochondria cannot generate enough acetyl-CoA. Without acetyl-CoA, the ChAT enzyme has nothing to work with. No acetylcholine gets produced, regardless of how much choline is present.^†

B5 is available in a range of foods, but chronic stress, poor diet quality, and gut dysfunction all reduce effective levels. People who have been under sustained physiological stress, recovering from illness, or relying on a heavily processed diet are commonly low.

This is the bottleneck that explains a lot of failed choline supplementation. You gave the brain more raw material. The assembly line was still stalled.

Step Three: The Assembly Enzyme That Genetics Can Slow

Even with adequate choline and acetyl-CoA, production can still fall short if ChAT is not functioning efficiently.

ChAT is the rate-limiting enzyme. It determines how fast acetylcholine gets assembled. Two factors impair it significantly.

APOE4 reduces ChAT activity directly

Post-mortem brain tissue from symptom-free APOE4 carriers shows measurably lower ChAT activity than non-carriers. No Alzheimer's. No symptoms. Just structurally reduced assembly capacity.⁴

The effect is dose-dependent. One copy of APOE4 reduces ChAT. Two copies reduces it further.⁵ APOE4 also reduces acetyl-CoA availability and the transporter that loads acetylcholine into vesicles for release. This is not one impairment. It is three simultaneous impairments across the production chain.

This starts earlier than most people realize. A 2019 analysis of 1,321 children and adolescents tracked IQ scores at ages 7, 12, and 16. APOE4 carriers scored lower across verbal, performance, and full-scale IQ from childhood onward. The effect was substantially larger in girls. Girls with one copy of APOE4 averaged 3.41 IQ points lower per allele. Boys: 0.33 points.⁹ The area hit hardest was the ability to think through problems and figure things out.

An APOE4 carrier arrives at any cognitive challenge, any illness, any period of sustained stress with a cholinergic system that was already running below capacity. Long before any diagnosis.

High homocysteine impairs ChAT directly

Elevated homocysteine does not just damage blood vessels. It directly impairs ChAT enzyme activity in the brain.⁶ It also causes excitotoxicity by overactivating NMDA receptors in the basal forebrain, the primary acetylcholine-producing region.

Homocysteine rises when B vitamins are insufficient, particularly folate, B12, and B6. It rises further in people with MTHFR gene variants that reduce folate conversion. Homocysteine spikes during illness and fever.

A standard blood panel does not include homocysteine. You have to ask for it specifically. Most people have never had it tested. Yet everyone should. And you want your homocysteine at 7 umol/L.

Even When You Make It, Something Destroys It

Fixing production is necessary but not sufficient. AChE, the enzyme that clears acetylcholine, becomes a problem when it is overactive.

Under normal conditions, AChE clears acetylcholine from the synapse in milliseconds. This is how the signal stays precise. The problem starts when neuroinflammation, elevated homocysteine, or persistent immune activation drives AChE activity higher than it should be.

Elevated homocysteine independently raises AChE activity in the hippocampus and cortex.⁷ More AChE means acetylcholine gets cleared faster. The signal weakens even when production has not changed.

This is the double hit that homocysteine delivers. It impairs ChAT on the production side. It upregulates AChE on the destruction side. Fix only methylation and some improvement follows. Fix only AChE inhibition without addressing methylation and the underlying damage continues.

Post-illness neuroinflammation adds another layer. Sustained microglial activation drives AChE upregulation. The brain produces some acetylcholine and the inflamed environment destroys it before it reaches the receptor. Nicotine temporarily bypasses this problem by activating the receptor directly. But the destruction cycle runs on.

The Genetic Factors That Amplify Every Deficit

Genetics do not cause acetylcholine depletion on their own. They set the baseline. Under stress, illness, poor nutrition, or aging, the people with these variants fall faster and recover slower.

Two genes matter most for acetylcholine specifically.

rsID	Gene	Variant	Prevalence	What It Does to Acetylcholine	Testable?	Impact
rs429358 + rs7412	APOE	E3/E4 or E4/E4	~25% carry 1 copy; ~2-3% carry 2 copies (European)	Reduces ChAT activity, acetyl-CoA supply, and VAChT expression. All three production steps impaired simultaneously.	Yes. Genetic test.	High. Lifelong structural deficit in ACh production.
rs1801133	MTHFR	C677T (TT or CT)	~10% TT in European; ~25% TT in Hispanic/Latino populations	Raises homocysteine. Elevated Hcy directly impairs ChAT and upregulates AChE. Double hit on production and protection.	Yes. Blood test + genetic.	Moderate to High. Worse under illness or stress.
rs1801131	MTHFR	A1298C (CC or AC)	~10-15% CC in most populations	Reduces BH4 and SAM availability. Compounds Hcy elevation when combined with C677T.	Yes. Genetic test.	Moderate. More significant when both MTHFR variants present.

APOE4 is particularly important to test before the next major illness. The cholinergic system of an APOE4 carrier cannot respond to acute physiological demand the same way a non-carrier's can. That difference explains a significant portion of who struggles with prolonged cognitive symptoms after viral infection.

MTHFR variants matter because homocysteine matters. Every 1 micromol/L rise in homocysteine correlates with measurable cognitive decline in post-COVID patients.⁸ The target is 7 micromol/L for neuroprotection, not the standard lab reference range of below 15.

Neither APOE4 nor homocysteine is routinely tested in standard care. You may have been walking around with both vulnerabilities active for years without knowing.

You Have Specific Deficits. All of Them Are Measurable.

Here is what shifts when you understand this correctly.

You are not dealing with a vague, untestable problem. You have a production chain with identifiable weak points. You have genetic factors that are testable with a single blood draw and a genetic panel. You have a blood marker, homocysteine, that tells you directly whether your methylation system is keeping up and whether ChAT and AChE are being damaged right now.

These are not mysteries. They are measurable deficits with targeted solutions.

The reason choline alone did not work is that it addressed one input of a three-input system. The reason nicotine stops working is that it activates receptors without adding any production capacity and desensitizes those receptors in the process.

Restoring acetylcholine production means addressing all three inputs, protecting what you make from premature destruction, and for some people, addressing the genetic amplifiers that have been compounding the problem silently.

Part 3 of this series covers the protocol. The specific nutrients. The correct sequence, which matters as much as the ingredients themselves. The signs that production is actually recovering. And why the nicotine craving reduces on its own as the deficit closes.

Coming in Part 3

The restoration protocol: the specific nutrients, the order in which they should be added, and why the sequence matters more than any single ingredient. What recovery actually looks and feels like. And how to tell when the deficit is genuinely closing rather than masked.

If you want to know your APOE4 and MTHFR status now, StrateGene generates a personalized report from your 23andMe or AncestryDNA raw data and maps your variants directly to the pathways covered in this series.

---

References

1. Wallace TC. Choline: the underconsumed and underappreciated essential nutrient. Nutrients. 2018;10(12):1965. PMID 30501064. https://pubmed.ncbi.nlm.nih.gov/30501064/
2. Resseguie ME, da Costa KA, Galanko JA et al. Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem. 2007;282(27):19336-19345. PMC2430895.
3. Fisher LM, da Costa KA, Kwock L et al. Dietary choline requirements of women: effects of estrogen and genetic variation. Am J Clin Nutr. 2010;92(5):1113-1119. PMID 20861172. https://pubmed.ncbi.nlm.nih.gov/20861172/
4. Allen SJ, Dawbarn D, MacGowan SH et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett. 1997;239(1):33-36. PMID 9547165.
5. Poirier J, Davignon J, Bouthillier D et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342(8873):697-699. PMID 7783963.
6. Sachdev PS. Homocysteine and brain atrophy. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(7):1152-1161. PMID 15694234. https://pubmed.ncbi.nlm.nih.gov/15694234/
7. Scherer EB, Loureiro SO, Marisco PC et al. Mild hyperhomocysteinemia increases brain acetylcholinesterase and pro-inflammatory cytokine levels in rats. Mol Neurobiol. 2014;50(2):589-596. PMID 24590316. [animal model] https://pubmed.ncbi.nlm.nih.gov/24590316/
8. Celik Y, Akdag Kose D, Tumkaya L et al. High homocysteine levels are associated with cognitive impairment in patients who recovered from COVID-19. Nutrients. 2023;15(3):503. PMC10056581.
9. Reynolds CA, Smolen A, Corley RP, Munoz E, Friedman NP, Rhee SH, Stallings MC, DeFries JC, Wadsworth SJ et al. APOE effects on cognition from childhood to adolescence. Neurobiol Aging. 2019 Dec;84:239.e1–239.e8. doi: 10.1016/j.neurobiolaging.2019.04.011. PMID 31126628. https://pubmed.ncbi.nlm.nih.gov/31126628/

^† This content is for educational purposes only and has not been evaluated by the Food and Drug Administration. It is not intended to diagnose, treat, cure, or prevent any disease.